Clinical Drug Experience Knowledgebase

dexmedetomidine (precedex) (4 trials)

polyethylene glycol (1 trial)

propofol (diprivan) (1 trial)

sennosides a&b (1 trial)

sodium chloride (1 trial)

amitriptyline (elavil) (1 trial)

bevacizumab (avastin) (3 trials)

bicalutamide (casodex) (2 trials)

buserelin (receptal) (2 trials)

calcitriol (rocaltrol) (1 trial)

carboplatin (paraplatin) (3 trials)

cisplatin (platinol) (5 trials)

custirsen (6 trials)

cyclophosphamide (cytoxan) (4 trials)

docetaxel (taxotere) (9 trials)

doxorubicin (Doxil) (3 trials)

flutamide (eulexin) (2 trials)

fulvestrant (faslodex) (1 trial)

gabapentin (neurontin) (1 trial)

goserelin (zoladex) (2 trials)

ipatasertib (2 trials)

ketamine (ketalar) (1 trial)

leuprolide (lupron) (1 trial)

lidocaine (xylocaine) (2 trials)

manuka honey (1 trial)

olaparib (lynparza) (3 trials)

paclitaxel (taxol) (4 trials)

prednisone (meticorten) (10 trials)

rituximab (rituxan) (4 trials)

sitagliptin (januvia) (2 trials)

sodium fluoride (18F) (1 trial)

technetium tc-99m medronate kit (1 trial)

topotecan (hycamtin) (1 trial)

trastuzumab (herceptin) (4 trials)

urea (4 trials)

vincristine (oncovin) (4 trials)

103-palladium (1 trial)

125-iodine (1 trial)

177lu-dotatoc (1 trial)

[68ga]ga-htk03149 (2 trials)

abiraterone (zytiga) (3 trials)

acetaminophen (tylenol) (1 trial)

adavosertib (1 trial)

alendronic acid (fosamax) (1 trial)

alvocidib (1 trial)

apatorsen (1 trial)

atezolizumab (Tecentriq) (1 trial)

axitinib (inlyta) (1 trial)

BA3011 (1 trial)

ba3021 (1 trial)

bortezomib (velcade) (1 trial)

bosutinib (bosulif) (1 trial)

brentuximab vedotin (adcetris) (1 trial)

budesonide (rhinocort) (2 trials)

cabazitaxel (jevtana kit) (1 trial)

cannabis (1 trial)

cfi-400945 (1 trial)

clindamycin (cleocin) (1 trial)

cobimetinib (cotellic) (1 trial)

crizotinib (xalkori) (1 trial)

cx 5461 (1 trial)

dacarbazine (dtic-dome) (1 trial)

darolutamide (Nubeqa) (1 trial)

dasatinib (sprycel) (1 trial)

degarelix acetate (firmagon) (2 trials)

denenicokin (1 trial)

dexamethasone (1 trial)

diphenhydramine (benadryl) (1 trial)

durvalumab (imfinzi) (6 trials)

enzalutamide (xtandi) (3 trials)

epi-506 (1 trial)

epothilone (1 trial)

erlotinib (tarceva) (3 trials)

etoposide (vepesid) (1 trial)

everolimus (zortress) (1 trial)

fludeoxyglucose f-18 (2 trials)

foretinib (2 trials)

gadobutrol (gadavist) (2 trials)

gemcitabine (gemzar) (6 trials)

glucose monohydrate (1 trial)

htk03170 (1 trial)

ifosfamide (ifex) (1 trial)

ipilimumab (yervoy) (1 trial)

ispinesib (2 trials)

lapatinib (tykerb) (2 trials)

letrozole (femara) (1 trial)

lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)

mesna (mesnex) (1 trial)

methadone (methadose) (1 trial)

midazolam (versed) (1 trial)

minocycline (minocin) (1 trial)

nimotuzumab (1 trial)

nivolumab (opdivo) (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

ondansetron (zofran) (1 trial)

osimertinib (tagrisso) (1 trial)

pacritinib (Vonjo) (1 trial)

palbociclib (ibrance) (2 trials)

pembrolizumab (keytruda) (2 trials)

pemetrexed (alimta) (1 trial)

perindopril (aceon) (1 trial)

pertuzumab (perjeta) (1 trial)

pracinostat (1 trial)

qbkpn (1 trial)

regorafenib (stivarga) (1 trial)

reolysin (1 trial)

rp-6306 (2 trials)

saracatinib (1 trial)

savolitinib (1 trial)

selumetinib (Koselugo) (1 trial)

slc-0111 (1 trial)

s-methionine (1 trial)

sonolisib (1 trial)

sorafenib (nexavar) (3 trials)

sunitinib (sutent) (2 trials)

tamoxifen (nolvadex) (1 trial)

tea (2 trials)

temsirolimus (torisel) (1 trial)

tremelimumab (Imjudo) (1 trial)

triamcinolone (kenalog) (1 trial)

vandetanib (caprelsa) (1 trial)

vemurafenib (zelboraf) (1 trial)

vismodegib (erivedge) (1 trial)

vitamin d3 (2 trials)

at9283 (1 trial)

devimistat (1 trial)

formoterol (foradil) (1 trial)

lurtotecan (1 trial)

monalizumab (1 trial)

myoinositol (1 trial)

oblimersen sodium (1 trial)

romidepsin (istodax) (1 trial)

voruciclib (1 trial)

18f-6-l-fluorodihydroxyphenylalanine (1 trial)

99mtc (1 trial)

citric acid (1 trial)

panitumumab (vectibix) (1 trial)

tetracaine (pontocaine) (1 trial)